Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

α-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson’s disease
Roberto Di Maio, Paul J. Barrett, Eric K. Hoffman, et al.
Science Translational Medicine (2016) Vol. 8, Iss. 342
Open Access | Times Cited: 524

Showing 1-25 of 524 citing articles:

Selective neuronal vulnerability in Parkinson disease
D. James Surmeier, José Á. Obeso, Glenda M. Halliday
Nature reviews. Neuroscience (2017) Vol. 18, Iss. 2, pp. 101-113
Open Access | Times Cited: 896
Mitochondrial dysfunction in Parkinson's disease
Anindita Bose, M. Flint Beal
Journal of Neurochemistry (2016) Vol. 139, Iss. S1, pp. 216-231
Open Access | Times Cited: 736
α-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies
Yvette C. Wong, Dimitri Krainc
Nature Medicine (2017) Vol. 23, Iss. 2, pp. 1-13
Open Access | Times Cited: 733
Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson’s disease
Emily M. Rocha, Briana De Miranda, Laurie H. Sanders
Neurobiology of Disease (2017) Vol. 109, pp. 249-257
Closed Access | Times Cited: 627
Protein misfolding in neurodegenerative diseases: implications and strategies
Patrick Sweeney, Hyunsun Park, Marc Baumann, et al.
Translational Neurodegeneration (2017) Vol. 6, Iss. 1
Open Access | Times Cited: 548
Role of neuroinflammation in neurodegeneration development
Weifeng Zhang, Dan Xiao, Qinwen Mao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 545
LRRK2 activation in idiopathic Parkinson’s disease
Roberto Di Maio, Eric K. Hoffman, Emily M. Rocha, et al.
Science Translational Medicine (2018) Vol. 10, Iss. 451
Open Access | Times Cited: 528
Development of Multifunctional Molecules as Potential Therapeutic Candidates for Alzheimer’s Disease, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis in the Last Decade
Masha G. Savelieff, Geewoo Nam, Juhye Kang, et al.
Chemical Reviews (2018) Vol. 119, Iss. 2, pp. 1221-1322
Closed Access | Times Cited: 482
Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing
Barry Boland, Wen H. Yu, Olga Corti, et al.
Nature Reviews Drug Discovery (2018) Vol. 17, Iss. 9, pp. 660-688
Open Access | Times Cited: 467
Oxidative stress and cellular pathologies in Parkinson’s disease
Lesly Puspita, Sun Young Chung, Jae‐Won Shim
Molecular Brain (2017) Vol. 10, Iss. 1
Open Access | Times Cited: 415
β2-Adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson’s disease
Shuchi Mittal, Kjetil Bjørnevik, Doo Soon Im, et al.
Science (2017) Vol. 357, Iss. 6354, pp. 891-898
Open Access | Times Cited: 392
Mitochondrial Dysfunction and Mitophagy in Parkinson’s Disease: From Mechanism to Therapy
Ana Belén Malpartida, Matthew G Williamson, Derek P. Narendra, et al.
Trends in Biochemical Sciences (2020) Vol. 46, Iss. 4, pp. 329-343
Open Access | Times Cited: 358
Parkinson’s Disease: Etiology, Neuropathology, and Pathogenesis
Antonina Kouli, Kelli Torsney, Wei‐Li Kuan
Codon Publications eBooks (2018), pp. 3-26
Open Access | Times Cited: 357
Alpha-Synuclein Oligomers—Neurotoxic Molecules in Parkinson's Disease and Other Lewy Body Disorders
Martin Ingelsson
Frontiers in Neuroscience (2016) Vol. 10
Open Access | Times Cited: 337
New insights into the complex role of mitochondria in Parkinson’s disease
Anne Grünewald, Kishore R. Kumar, Carolyn M. Sue
Progress in Neurobiology (2018) Vol. 177, pp. 73-93
Open Access | Times Cited: 335
α-Synuclein binds to the ER–mitochondria tethering protein VAPB to disrupt Ca2+ homeostasis and mitochondrial ATP production
Sébastien Paillusson, Patricia Gómez‐Suaga, Radu Stoica, et al.
Acta Neuropathologica (2017) Vol. 134, Iss. 1, pp. 129-149
Open Access | Times Cited: 314
Autophagy in Parkinson's Disease
Xu Hou, Jens O. Watzlawik, Fabienne C. Fiesel, et al.
Journal of Molecular Biology (2020) Vol. 432, Iss. 8, pp. 2651-2672
Open Access | Times Cited: 280
The Role of Mitochondria in Neurodegenerative Diseases: the Lesson from Alzheimer’s Disease and Parkinson’s Disease
Giacomo Monzio Compagnoni, Alessio Di Fonzo, Stefania Corti, et al.
Molecular Neurobiology (2020) Vol. 57, Iss. 7, pp. 2959-2980
Open Access | Times Cited: 280
Alpha-synuclein in Parkinson’s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction
Paolo Calabresi, Alessandro Mechelli, Giuseppina Natale, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 3
Open Access | Times Cited: 277
Targeting Alpha-Synuclein as a Therapy for Parkinson’s Disease
Carroll Rutherford Fields, Nora Bengoa‐Vergniory, Richard Wade‐Martins
Frontiers in Molecular Neuroscience (2019) Vol. 12
Open Access | Times Cited: 276
Like prions: the propagation of aggregated tau and α-synuclein in neurodegeneration
Michel Goedert, Masami Masuda‐Suzukake, Benjamin Falcon
Brain (2016) Vol. 140, Iss. 2, pp. 266-278
Open Access | Times Cited: 269
Proteinopathy, oxidative stress and mitochondrial dysfunction: cross talk in Alzheimer's disease and Parkinson's disease
Gargi Ganguly, Sasanka Chakrabarti, Uttara Chatterjee, et al.
Drug Design Development and Therapy (2017) Vol. Volume11, pp. 797-810
Open Access | Times Cited: 241
Mitochondrial impairment in microglia amplifies NLRP3 inflammasome proinflammatory signaling in cell culture and animal models of Parkinson’s disease
Souvarish Sarkar, Emir Malovic, Dilshan S. Harishchandra, et al.
npj Parkinson s Disease (2017) Vol. 3, Iss. 1
Open Access | Times Cited: 236
The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases
Nolwen L. Rey, Daniel W. Wesson, Patrik Brundin
Neurobiology of Disease (2016) Vol. 109, pp. 226-248
Open Access | Times Cited: 230
Mitochondrial Dysfunction in Parkinson’s Disease—Cause or Consequence?
Chun Chen, Douglass M. Turnbull, Amy K. Reeve
Biology (2019) Vol. 8, Iss. 2, pp. 38-38
Open Access | Times Cited: 224
Page 1 - Next Page

Scroll to top